Therefore, in the present study, MMP9 and sST2, promising biomarkers for cardiac fibrosis and hypertrophy, and CRP, a conventional biomarker for inflammation [11], were measured in addition to echocardiography. Here, MMP9 is linked to cardiac hypertrophy.